Last reviewed · How we verify

early cessation of steroids

University of Cincinnati · FDA-approved active Small molecule

early cessation of steroids is a Small molecule drug developed by University of Cincinnati. It is currently FDA-approved for Clinical protocol for reducing steroid-related adverse effects in steroid-responsive conditions. Also known as: prednisone, various.

Early cessation of steroids reduces prolonged immunosuppression and associated adverse effects by discontinuing corticosteroid therapy at an earlier timepoint than standard practice.

Early cessation of steroids reduces prolonged immunosuppression and associated adverse effects by discontinuing corticosteroid therapy at an earlier timepoint than standard practice. Used for Clinical protocol for reducing steroid-related adverse effects in steroid-responsive conditions.

At a glance

Generic nameearly cessation of steroids
Also known asprednisone, various
SponsorUniversity of Cincinnati
ModalitySmall molecule
Therapeutic areaImmunology / General Medicine
PhaseFDA-approved

Mechanism of action

This represents a clinical practice or protocol modification rather than a novel drug entity. Early steroid discontinuation aims to minimize cumulative steroid exposure, thereby reducing risks of infection, metabolic complications, and other steroid-related toxicities while maintaining therapeutic efficacy. The approach is typically studied in conditions where steroids are used as adjunctive or short-term therapy.

Approved indications

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about early cessation of steroids

What is early cessation of steroids?

early cessation of steroids is a Small molecule drug developed by University of Cincinnati, indicated for Clinical protocol for reducing steroid-related adverse effects in steroid-responsive conditions.

How does early cessation of steroids work?

Early cessation of steroids reduces prolonged immunosuppression and associated adverse effects by discontinuing corticosteroid therapy at an earlier timepoint than standard practice.

What is early cessation of steroids used for?

early cessation of steroids is indicated for Clinical protocol for reducing steroid-related adverse effects in steroid-responsive conditions.

Who makes early cessation of steroids?

early cessation of steroids is developed and marketed by University of Cincinnati (see full University of Cincinnati pipeline at /company/university-of-cincinnati).

Is early cessation of steroids also known as anything else?

early cessation of steroids is also known as prednisone, various.

What development phase is early cessation of steroids in?

early cessation of steroids is FDA-approved (marketed).

Related